MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-06-0004141
Market Cap
₹502 Cr
KRMAYURVED-SM · NSE
Share Price
₹225.45
-4.47% today
Revenue
₹102 Cr
FY 2025-26 · +32.8% YoY
EBITDA
₹30.50 Cr
Margin 30.0%
Net Profit
₹20.13 Cr
FY 2025-26 · +66.5% YoY
Authorised capital
₹25 Cr
Registered with MCA
Paid-up capital
₹15.52 Cr
Issued & subscribed
Open charges
₹27.05 Cr
Secured borrowings
About KRM Ayurveda Limited
Data last updated:
KRM Ayurveda Limited is a public limited company based in Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 03 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2019PLC354658. Its GSTIN is 07AAHCK7844G1Z9 (Delhi). The company holds 9 GST registrations, of which 7 are active. It is a listed company as per MCA records. Its shares are listed on NSE: KRMAYURVED.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹15.52 Cr. It is led by directors including Puneet Dhawan (Managing Director) and Sanchit Hans (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2026. The registered office is at A – 16 G T Karnal Road Industrial Area, Delhi, India – 110033.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹101.69 Cr, a growth of 32.8% compared to the previous year. For the same year it recorded a net profit of ₹20.13 Cr (net margin 19.8%) and EBITDA of ₹30.5 Cr (EBITDA margin 30%). The net worth stands at ₹114.71 Cr (up 380% YoY). Total assets are valued at ₹115.46 Cr (up 107% YoY).
The company has about 131 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: KRM Ayurveda. As per MCA filings, the company has open charges of ₹27.05 Cr on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending. The company has 10 deals on record (9 secondary share transfers, 1 ipo); the latest was in January 2026. Its 7 peer companies in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Eskay Herbal Formulations Private Limited with revenue of ₹72.88 Cr.
KRM Ayurveda Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0004141). For more details, the company can be reached via its website krmayurveda.com.
Company details
CIN U24239DL2019PLC354658
Registration Number 354658
Incorporation Date 03 September 2019
ROC Delhi
Listing Status Listed (NSE: KRMAYURVED)
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2026
MSME Classification Medium
Udyam Registration UDYAM-DL-06-0004141
CIN history
KRM Ayurveda has one previous CIN (Corporate Identification Number): U24239DL2019PTC354658. The current CIN is U24239DL2019PLC354658, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239DL2019PLC354658 | Current |
| U24239DL2019PTC354658 | Previous |
Recognitions & Rankings of KRM Ayurveda
Contact details
KRM Ayurveda Limited's registered office is in Delhi, Delhi. Its website is krmayurveda.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 16 G T Karnal Road Industrial Area, Delhi, India – 110033
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of KRM Ayurveda Limited, buy the company report.
Comprehensive company report
KRM Ayurveda Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
KRM Ayurveda operates one associated brand: KRM Ayurveda. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| KRM Ayurveda offers comprehensive consultancy services in yoga, diet, and medications for holistic well-being. | krmayurveda.com |
Business activity
The main business activities of KRM Ayurveda are manufacturing and hospital and medical care. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of KRM Ayurveda Limited, buy the company report.
Financials of KRM Ayurveda Limited
FY 2025-26 filings availableKRM Ayurveda Limited reported revenue of ₹101.69 Cr (up 32.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue
₹102 Cr
+32.8% YoY
EBITDA
₹30.50 Cr
+56.7% YoY
Profit After Tax
₹20.13 Cr
+66.5% YoY
Net Worth
₹115 Cr
+380.0% YoY
Total Assets
₹115 Cr
+107.0% YoY
Total Debt
Nil
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 102 | 76.55 | 67.16 | 89.29 |
| Revenue growth | +32.8% | +14.0% | -24.8% | - |
| EBITDA | 30.50 | 19.47 | 7.62 | 11.18 |
| EBITDA margin | +30.0% | +25.4% | +11.4% | +12.5% |
| Profit before tax | 26.73 | 16.34 | 4.74 | 10.08 |
| Net profit | 20.13 | 12.09 | 3.43 | 7.59 |
| Net profit margin | +19.8% | +15.8% | +5.1% | +8.5% |
| EPS (₹) | 9.46 | 806.48 | 2,274.80 | 5,065.33 |
| Balance sheet | ||||
| Total assets | 115 | 55.78 | 35.34 | 28.47 |
| Net worth | 115 | 23.90 | 11.78 | 8.37 |
| Total debt | 0.00 | 31.20 | 23.18 | 19.87 |
| Cash & bank | 9.47 | 2.04 | 0.50 | 0.23 |
| Net working capital | 49.35 | 19.43 | 11.98 | 4.66 |
| Cash flow | ||||
| Cash from operations | 1.12 | 3.49 | (0.89) | 3.51 |
| Cash from investing | (30.50) | (7.85) | (0.13) | (22.94) |
| Cash from financing | 36.81 | 5.90 | 1.29 | 19.47 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 32.32 | 32.21 | 21.12 | 23.69 | 24.67 |
| Revenue growth (YoY) | +31.0% | - | - | - | - |
| Other income | 0.54 | 0.19 | 0.14 | 0.15 | 0.15 |
| Total expenses | 20.30 | 21.22 | 14.57 | 17.07 | 18.45 |
| EBITDA | 12.02 | 10.99 | 6.55 | 6.62 | 6.22 |
| EBITDA margin | +37.2% | +34.1% | +31.0% | +27.9% | +25.2% |
| Depreciation | 0.26 | 0.31 | 0.30 | 0.28 | 0.25 |
| Interest | 0.06 | 0.63 | 0.91 | 0.90 | 0.69 |
| Profit before tax | 12.24 | 10.24 | 5.48 | 5.59 | 5.43 |
| Tax | 3.15 | 2.42 | 1.40 | 1.49 | 1.37 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 30 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 32.32 | 32.21 | 21.12 | 23.69 | 24.67 |
| Revenue growth (YoY) | +31.0% | - | - | - | - |
| Other income | 0.54 | 0.19 | 0.14 | 0.15 | 0.15 |
| Total expenses | 20.30 | 21.22 | 14.57 | 17.07 | 18.45 |
| EBITDA | 12.02 | 10.99 | 6.55 | 6.62 | 6.22 |
| EBITDA margin | +37.2% | +34.1% | +31.0% | +27.9% | +25.2% |
| Depreciation | 0.26 | 0.31 | 0.30 | 0.28 | 0.25 |
| Interest | 0.06 | 0.63 | 0.91 | 0.90 | 0.69 |
| Profit before tax | 12.24 | 10.24 | 5.48 | 5.59 | 5.43 |
| Tax | 3.15 | 2.42 | 1.40 | 1.49 | 1.37 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Revenue | 102 | 76.55 | 67.16 | 89.29 |
| Revenue growth | +32.8% | +14.0% | -24.8% | - |
| Other income | 0.62 | 0.40 | 0.42 | 0.09 |
| Total expenses | 71.19 | 57.08 | 59.54 | 78.11 |
| Employee cost | 0.00 | 17.12 | 18.70 | 18.32 |
| EBITDA | 30.50 | 19.47 | 7.62 | 11.18 |
| EBITDA margin | +30.0% | +25.4% | +11.4% | +12.5% |
| Depreciation | 1.14 | 1.04 | 1.02 | 0.64 |
| Interest | 3.25 | 2.49 | 2.28 | 0.55 |
| Profit before tax | 26.73 | 16.34 | 4.74 | 10.08 |
| Tax | 6.60 | 4.25 | 1.31 | 2.49 |
| Net profit | 20.13 | 12.09 | 3.43 | 7.59 |
| Net profit margin | +19.8% | +15.8% | +5.1% | +8.5% |
| EPS (₹) | 9.46 | 806.48 | 2,274.80 | 5,065.33 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Equity & liabilities | ||||
| Share capital | 21.26 | 0.15 | 0.15 | 0.15 |
| Reserves & surplus | 93.45 | 23.75 | 11.63 | 8.22 |
| Shareholders' funds (net worth) | 115 | 23.90 | 11.78 | 8.37 |
| Secured loans | 0.00 | 31.20 | 23.18 | 19.42 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 0.45 |
| Total debt | 0.00 | 31.20 | 23.18 | 19.87 |
| Total liabilities | 115 | 55.78 | 35.34 | 28.47 |
| Assets | ||||
| Gross block | 30.88 | 29.97 | 25.24 | 24.71 |
| Net block | 26.33 | 26.56 | 22.87 | 23.36 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 38.30 | 8.80 | 0.00 | 0.00 |
| Inventories | 9.03 | 7.70 | 1.45 | 0.67 |
| Sundry debtors | 22.73 | 12.13 | 5.53 | 7.76 |
| Cash & bank balances | 9.47 | 2.04 | 0.50 | 0.23 |
| Loans & advances | 14.93 | 8.47 | 13.06 | 7.01 |
| Total current assets | 56.16 | 30.34 | 20.54 | 15.67 |
| Total current liabilities | 6.81 | 10.91 | 8.56 | 11.01 |
| Net working capital | 49.35 | 19.43 | 11.98 | 4.66 |
| Total assets | 115 | 55.78 | 35.34 | 28.47 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Opening cash | 2.04 | 0.50 | 0.23 | 0.71 |
| Net cash from operating activities | 1.12 | 3.49 | (0.89) | 3.51 |
| Net cash from investing activities | (30.50) | (7.85) | (0.13) | (22.94) |
| Net cash from financing activities | 36.81 | 5.90 | 1.29 | 19.47 |
| Net change in cash | 7.43 | 1.54 | 0.27 | 0.05 |
| Closing cash | 9.47 | 2.04 | 0.50 | 0.23 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|---|
| Growth | ||||
| Sales growth | +32.8% | +14.0% | -24.8% | - |
| EBITDA growth | +56.7% | +155.5% | -31.8% | - |
| PBT growth | +63.6% | +244.7% | -53.0% | +9997.0% |
| Net income growth | +66.5% | +252.5% | -54.8% | - |
| Revenue CAGR (3Y) | +4.4% | - | - | - |
| EBITDA CAGR (3Y) | +39.7% | - | - | - |
| Profitability & leverage | ||||
| Net income margin | +19.8% | +15.8% | +5.1% | +8.5% |
| Return on capital employed | - | +41.3% | +21.9% | +37.4% |
| Return on net worth | - | +67.9% | +33.9% | +90.8% |
| Debt / equity | - | 1.52 | 2.14 | 2.37 |
| Long-term debt / equity | - | 1.10 | 1.89 | 2.11 |
| Interest cover | 11.07 | 13.51 | 34.55 | 5.22 |
| Efficiency & per share | ||||
| Fixed asset turnover | - | 2.77 | 2.69 | 3.61 |
| Inventory turnover | - | 16.73 | 63.36 | 133.27 |
| Debtors turnover | - | 8.67 | 10.11 | 11.51 |
| EPS (₹) | 9.46 | 806.48 | 2,274.80 | 5,065.33 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 1,591.72 | 7,852.33 | 5,577.53 |
To see the full year-wise statements and ratios of KRM Ayurveda Limited, buy the company report.
Board of directors of KRM Ayurveda Limited
KRM Ayurveda has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanchit Hans | Whole-Time Director | 24 Feb 2023 | 3 Years 8 Months | Current |
| Puneet Dhawan | Managing Director | 03 Sep 2019 | 7 Years 1 Months | Current |
| Tanya Dhawan | Director | 30 Sep 2024 | 2 Years 1 Months | Current |
| Vandana Gupta Also directs: Kra Leasing Limited, Bharat Ekansh Limited, Blue Horizon Investments Limited and 2 more | Director | 21 Jan 2025 | 1 Years 9 Months | Current |
| Laxmi Also directs: Weare8 India Media Private Limited | Director | 21 Jan 2025 | 1 Years 9 Months | Current |
Peer comparison
KRM Ayurveda Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| KRM Ayurveda Limitedthis company | ₹101.69 Cr (FY 2026) | ₹20.13 Cr | 19.8% | 32.8% | 131 | Delhi, India |
| Eskay Herbal Formulations Private Limited | ₹72.88 Cr (FY 2025) | -3.0% | Jalgaon, Maharashtra, India | |||
| Prakruti Products Private Limited | ₹69.57 Cr (FY 2024) | 13.0% | Karantaka, Karnataka, India | |||
| Kumaon Exports Private Limited | ₹68.75 Cr (FY 2025) | 8.0% | Dehradun, Uttarakhand, India | |||
| Sandu Pharmaceuticals Limited | ₹67.36 Cr (FY 2025) | -1.0% | Goa, India | |||
| Valyou Products Private Limited | ₹65.07 Cr (FY 2024) | -6.0% | Shimoga, Karnataka, India | |||
| Atiya Healthcare Private Limited | ₹64.78 Cr (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Pankaja Kasthuri Herbals India Private Limited | ₹64.4 Cr (FY 2025) | -7.0% | Thiruvananthapuram, Kerala, India |
To see the full peer comparison of KRM Ayurveda Limited, buy the company report.
Auditor
KRM Ayurveda Limited is audited by S.C. KWATRA & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S.C. KWATRA & CO. | FY 2024 | 004232N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 69.20%, foreign institutional investors hold 3.80%, domestic institutional investors hold 3.40% and retail and other public shareholders hold 23.70%.
Sep 2026
QUARTER
69.20% Promoters
3.40% DII (Domestic Institutional)
3.80% FII (Foreign Institutional)
23.70% Retail & Others
Promoter holding - history
Now 69.20% · Sep 2026High 69.20% · Jun 2026Low 69.20% · Jun 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | |
|---|---|---|
| Promoters | 69.20% | 69.20% |
| Public | 30.80% | 30.80% |
Charges & borrowings
Open charges
₹27.05 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Apr 2023 | 100710457 | Others | ₹21.3 Cr | Open | |
| 03 Jan 2023 | 100661051 | Others | ₹5.75 Cr | Open |
To see the full charge records of KRM Ayurveda Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
KRM Ayurveda Limited has 10 deals on record (9 secondary share transfers, 1 ipo); the latest was in January 2026.
Total deals
10
Secondary share transfers
9
IPO
1
Deals on record (5 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2026 | IPO | ₹77.49 Cr | Investors: Pine Oak Global Fund, Cognizant Capital Dynamic Opportunities Fund, SageOne India Opportunity Trust |
| Jul 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2025 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Jul 2025 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
To see the full deal history of KRM Ayurveda Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
KRM Ayurveda Limited has 1 court case on record: 1 filed by KRM Ayurveda. All case is pending.
Total cases
1
Filed by the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of KRM Ayurveda Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for KRM Ayurveda Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
KRM Ayurveda Limited has a workforce of 131 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
131
Active EPFO establishments
1
Employee growth
-25.99%
GST
KRM Ayurveda has 9 GST registrations: 7 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
9
Active
7
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAHCK7844G1Z9 | Delhi | Active | 30 Sep 2019 |
| 06AAHCK7844G1ZB | Haryana | Active | 30 Apr 2021 |
| 27AAHCK7844G1Z7 | Maharashtra | Active | 23 Aug 2022 |
| 29AAHCK7844G1Z3 | Karnataka | Active | 07 Dec 2022 |
To see the full GST registrations and return filing status of KRM Ayurveda Limited, buy the company report.
Recent activity
KRM Ayurveda Limited has 9 board changes on record since 2019: 5 appointments and 4 cessations. The latest: Puneet Dhawan ceased to be Director on 14 Mar 2025.
Filing
Krm Ayurveda Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Delhi.
Ceased
Puneet Dhawan ceased to be Director.
Appointed
Laxmi was appointed as Director.
Appointed
Vandana Gupta was appointed as Director.
Ceased
Som Dev Dhawan ceased to be Director.
AGM
Krm Ayurveda Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Tanya Dhawan was appointed as Director.
Charges
A charge with Others of Rs. 21.30 Cr registered on 17 Apr 2023 with Charge ID 100710457 was modified on 30 Jun 2024.
Charges
A charge with Others of Rs. 5.75 Cr registered on 03 Jan 2023 with Charge ID 100661051 was modified on 30 Jun 2024.
Charges
A charge with Others amounted to Rs. 21.30 Cr with Charge ID 100710457 was registered on 17 Apr 2023.
Appointed
Sanchit Hans was appointed as Whole-Time Director.
Charges
A charge with Others amounted to Rs. 5.75 Cr with Charge ID 100661051 was registered on 03 Jan 2023.
4 earlier events are in the company report.
Frequently asked questions
KRM Ayurveda is an active public limited company based in Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 03 September 2019 (7+ years old) and is registered under CIN U24239DL2019PLC354658. Listed on NSE: KRMAYURVED.
KRM Ayurveda reported revenue of ₹101.69 Cr for FY 2025-26 (up 32.8% YoY) based on standalone financials.
KRM Ayurveda has 5 current directors:
- Puneet Dhawan - Managing Director
- Sanchit Hans - Whole-Time Director
- Tanya Dhawan - Director
- Vandana Gupta - Director
- Laxmi - Director
The latest financial statements of KRM Ayurveda on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of KRM Ayurveda is 07AAHCK7844G1Z9, registered in Delhi. The company has 9 GST registrations in all, of which 7 are active and 2 are cancelled or inactive. Other active GSTINs include 06AAHCK7844G1ZB (Haryana), 27AAHCK7844G1Z7 (Maharashtra), 29AAHCK7844G1Z3 (Karnataka).
The CIN (Corporate Identification Number) of KRM Ayurveda is U24239DL2019PLC354658. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. KRM Ayurveda is a listed company as per MCA records. Its shares are listed on NSE (symbol: KRMAYURVED).
KRM Ayurveda has 1 court case on record: 1 filed by the company. 1 is pending.
KRM Ayurveda was incorporated on 03 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
KRM Ayurveda has 10 deals on record (9 secondary share transfers, 1 ipo); the latest was in January 2026.
The peers of KRM Ayurveda by revenue are Eskay Herbal Formulations Private Limited, Prakruti Products Private Limited, Kumaon Exports Private Limited, Sandu Pharmaceuticals Limited, Valyou Products Private Limited and 2 more, all in the Healthcare industry (Ayurvedic Products and Services), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages